We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Clarify Expectations on Off-Label Use by Year’s End
FDA to Clarify Expectations on Off-Label Use by Year’s End
The FDA plans to clear up questions about the types of off-label information drugmakers may communicate to physicians and payers in a series of guidances planned for later this year that will address four key areas that have long tripped up industry.